ID   CDKL2_HUMAN             Reviewed;         493 AA.
AC   Q92772; B2R695;
DT   22-NOV-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1997, sequence version 1.
DT   12-OCT-2022, entry version 168.
DE   RecName: Full=Cyclin-dependent kinase-like 2 {ECO:0000305};
DE            EC=2.7.11.22;
DE   AltName: Full=Protein kinase p56 KKIAMRE {ECO:0000303|PubMed:9000130};
DE   AltName: Full=Serine/threonine-protein kinase KKIAMRE;
GN   Name=CDKL2 {ECO:0000312|HGNC:HGNC:1782};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RC   TISSUE=Fetal brain;
RX   PubMed=9000130;
RA   Taglienti C.A., Wysk M., Davis R.J.;
RT   "Molecular cloning of the epidermal growth factor-stimulated protein kinase
RT   p56 KKIAMRE.";
RL   Oncogene 13:2563-2574(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5] {ECO:0007744|PDB:4AAA, ECO:0007744|PDB:4BBM}
RP   X-RAY CRYSTALLOGRAPHY (1.53 ANGSTROMS) OF 1-308 IN COMPLEX WITH SYNTHETIC
RP   INHIBITOR.
RX   PubMed=29420175; DOI=10.1016/j.celrep.2017.12.083;
RA   Canning P., Park K., Goncalves J., Li C., Howard C.J., Sharpe T.D.,
RA   Holt L.J., Pelletier L., Bullock A.N., Leroux M.R.;
RT   "CDKL Family Kinases Have Evolved Distinct Structural Features and Ciliary
RT   Function.";
RL   Cell Rep. 22:885-894(2018).
RN   [6]
RP   VARIANTS [LARGE SCALE ANALYSIS] ILE-98; GLN-149; THR-197 AND VAL-411.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.22;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.22;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:9000130}. Nucleus
CC       {ECO:0000269|PubMed:9000130}.
CC   -!- TISSUE SPECIFICITY: Expressed in testis and kidney, and at lower level
CC       in brain and lung. {ECO:0000269|PubMed:9000130}.
CC   -!- DOMAIN: The [NKR]KIAxRE motif seems to be a cyclin-binding region.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC Ser/Thr
CC       protein kinase family. CDC2/CDKX subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U35146; AAC50918.1; -; mRNA.
DR   EMBL; AK312490; BAG35392.1; -; mRNA.
DR   EMBL; CH471057; EAX05740.1; -; Genomic_DNA.
DR   EMBL; BC093646; AAH93646.1; -; mRNA.
DR   EMBL; BC093981; AAH93981.1; -; mRNA.
DR   CCDS; CCDS3570.1; -.
DR   RefSeq; NP_001317653.1; NM_001330724.1.
DR   RefSeq; NP_003939.1; NM_003948.4.
DR   RefSeq; XP_016864299.1; XM_017008810.1.
DR   PDB; 4AAA; X-ray; 1.53 A; A=1-308.
DR   PDB; 4BBM; X-ray; 2.00 A; A/B=1-308.
DR   PDBsum; 4AAA; -.
DR   PDBsum; 4BBM; -.
DR   AlphaFoldDB; Q92772; -.
DR   SMR; Q92772; -.
DR   BioGRID; 114479; 11.
DR   IntAct; Q92772; 66.
DR   STRING; 9606.ENSP00000412365; -.
DR   BindingDB; Q92772; -.
DR   ChEMBL; CHEMBL5728; -.
DR   DrugBank; DB12010; Fostamatinib.
DR   DrugCentral; Q92772; -.
DR   iPTMnet; Q92772; -.
DR   PhosphoSitePlus; Q92772; -.
DR   BioMuta; CDKL2; -.
DR   DMDM; 74762639; -.
DR   EPD; Q92772; -.
DR   MassIVE; Q92772; -.
DR   MaxQB; Q92772; -.
DR   PaxDb; Q92772; -.
DR   PeptideAtlas; Q92772; -.
DR   PRIDE; Q92772; -.
DR   Antibodypedia; 24675; 250 antibodies from 27 providers.
DR   DNASU; 8999; -.
DR   Ensembl; ENST00000429927.6; ENSP00000412365.2; ENSG00000138769.11.
DR   GeneID; 8999; -.
DR   KEGG; hsa:8999; -.
DR   UCSC; uc003hiq.4; human.
DR   CTD; 8999; -.
DR   DisGeNET; 8999; -.
DR   GeneCards; CDKL2; -.
DR   HGNC; HGNC:1782; CDKL2.
DR   HPA; ENSG00000138769; Tissue enhanced (brain, choroid plexus, retina, testis).
DR   MIM; 603442; gene.
DR   neXtProt; NX_Q92772; -.
DR   OpenTargets; ENSG00000138769; -.
DR   PharmGKB; PA26318; -.
DR   VEuPathDB; HostDB:ENSG00000138769; -.
DR   eggNOG; KOG0593; Eukaryota.
DR   GeneTree; ENSGT00940000160368; -.
DR   HOGENOM; CLU_000288_136_0_1; -.
DR   InParanoid; Q92772; -.
DR   PhylomeDB; Q92772; -.
DR   TreeFam; TF101031; -.
DR   PathwayCommons; Q92772; -.
DR   SignaLink; Q92772; -.
DR   BioGRID-ORCS; 8999; 18 hits in 1101 CRISPR screens.
DR   ChiTaRS; CDKL2; human.
DR   GeneWiki; CDKL2; -.
DR   GenomeRNAi; 8999; -.
DR   Pharos; Q92772; Tchem.
DR   PRO; PR:Q92772; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   RNAct; Q92772; protein.
DR   Bgee; ENSG00000138769; Expressed in endothelial cell and 145 other tissues.
DR   ExpressionAtlas; Q92772; baseline and differential.
DR   Genevisible; Q92772; HS.
DR   GO; GO:0005813; C:centrosome; IDA:HPA.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004693; F:cyclin-dependent protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0004672; F:protein kinase activity; TAS:ProtInc.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0006468; P:protein phosphorylation; IBA:GO_Central.
DR   GO; GO:0007548; P:sex differentiation; TAS:ProtInc.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Cytoplasm; Kinase; Nucleotide-binding; Nucleus;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..493
FT                   /note="Cyclin-dependent kinase-like 2"
FT                   /id="PRO_0000085814"
FT   DOMAIN          4..287
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          363..384
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           45..51
FT                   /note="[NKR]KIAxRE"
FT   ACT_SITE        126
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         10..18
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         33
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   VARIANT         77
FT                   /note="Y -> S (in dbSNP:rs35921414)"
FT                   /id="VAR_053928"
FT   VARIANT         98
FT                   /note="L -> I (in an ovarian papillary serous
FT                   adenocarcinoma sample; somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041987"
FT   VARIANT         132
FT                   /note="I -> T (in dbSNP:rs17000707)"
FT                   /id="VAR_053929"
FT   VARIANT         149
FT                   /note="R -> Q (in an ovarian mucinous carcinoma sample;
FT                   somatic mutation; dbSNP:rs755711267)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041988"
FT   VARIANT         197
FT                   /note="M -> T (in dbSNP:rs56343717)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041989"
FT   VARIANT         411
FT                   /note="A -> V (in dbSNP:rs56231363)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041990"
FT   HELIX           1..3
FT                   /evidence="ECO:0007829|PDB:4AAA"
FT   STRAND          4..9
FT                   /evidence="ECO:0007829|PDB:4AAA"
FT   HELIX           10..13
FT                   /evidence="ECO:0007829|PDB:4AAA"
FT   STRAND          16..23
FT                   /evidence="ECO:0007829|PDB:4AAA"
FT   TURN            24..26
FT                   /evidence="ECO:0007829|PDB:4AAA"
FT   STRAND          29..37
FT                   /evidence="ECO:0007829|PDB:4AAA"
FT   HELIX           42..57
FT                   /evidence="ECO:0007829|PDB:4AAA"
FT   STRAND          66..72
FT                   /evidence="ECO:0007829|PDB:4AAA"
FT   STRAND          75..81
FT                   /evidence="ECO:0007829|PDB:4AAA"
FT   STRAND          84..86
FT                   /evidence="ECO:0007829|PDB:4AAA"
FT   HELIX           87..93
FT                   /evidence="ECO:0007829|PDB:4AAA"
FT   HELIX           100..119
FT                   /evidence="ECO:0007829|PDB:4AAA"
FT   HELIX           129..131
FT                   /evidence="ECO:0007829|PDB:4AAA"
FT   STRAND          132..134
FT                   /evidence="ECO:0007829|PDB:4AAA"
FT   STRAND          140..142
FT                   /evidence="ECO:0007829|PDB:4AAA"
FT   HELIX           147..150
FT                   /evidence="ECO:0007829|PDB:4BBM"
FT   HELIX           154..163
FT                   /evidence="ECO:0007829|PDB:4BBM"
FT   HELIX           165..167
FT                   /evidence="ECO:0007829|PDB:4BBM"
FT   HELIX           170..173
FT                   /evidence="ECO:0007829|PDB:4AAA"
FT   HELIX           182..197
FT                   /evidence="ECO:0007829|PDB:4AAA"
FT   HELIX           207..218
FT                   /evidence="ECO:0007829|PDB:4AAA"
FT   HELIX           223..231
FT                   /evidence="ECO:0007829|PDB:4AAA"
FT   HELIX           233..235
FT                   /evidence="ECO:0007829|PDB:4AAA"
FT   HELIX           249..252
FT                   /evidence="ECO:0007829|PDB:4AAA"
FT   HELIX           258..267
FT                   /evidence="ECO:0007829|PDB:4AAA"
FT   HELIX           272..274
FT                   /evidence="ECO:0007829|PDB:4AAA"
FT   HELIX           278..283
FT                   /evidence="ECO:0007829|PDB:4AAA"
FT   HELIX           285..288
FT                   /evidence="ECO:0007829|PDB:4AAA"
FT   HELIX           289..291
FT                   /evidence="ECO:0007829|PDB:4AAA"
FT   HELIX           292..301
FT                   /evidence="ECO:0007829|PDB:4AAA"
SQ   SEQUENCE   493 AA;  56019 MW;  5CC20A91CBF89EFE CRC64;
     MEKYENLGLV GEGSYGMVMK CRNKDTGRIV AIKKFLESDD DKMVKKIAMR EIKLLKQLRH
     ENLVNLLEVC KKKKRWYLVF EFVDHTILDD LELFPNGLDY QVVQKYLFQI INGIGFCHSH
     NIIHRDIKPE NILVSQSGVV KLCDFGFART LAAPGEVYTD YVATRWYRAP ELLVGDVKYG
     KAVDVWAIGC LVTEMFMGEP LFPGDSDIDQ LYHIMMCLGN LIPRHQELFN KNPVFAGVRL
     PEIKEREPLE RRYPKLSEVV IDLAKKCLHI DPDKRPFCAE LLHHDFFQMD GFAERFSQEL
     QLKVQKDARN VSLSKKSQNR KKEKEKDDSL VEERKTLVVQ DTNADPKIKD YKLFKIKGSK
     IDGEKAEKGN RASNASCLHD SRTSHNKIVP STSLKDCSNV SVDHTRNPSV AIPPLTHNLS
     AVAPSINSGM GTETIPIQGY RVDEKTKKCS IPFVKPNRHS PSGIYNINVT TLVSGPPLSD
     DSGADLPQME HQH
//
